Medulloblastoma--treatment and prognosis. A study of seventeen cases in ten years.
In a series of 17 biopsy-proved cases of medulloblastoma all patients were treated by megavoltage irradiation in the Stanford University Division of Radiation Therapy. The entire craniospinal axis was treated in each case. The five-year survival in the series was 27 percent. Two ten-year survivors were studied in detail. The major longterm disability was inhibition of growth of the vertebral column. In this series, a normal tissue nominal standard dose of at least 1275 rets was necessary for tumor control.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008527:Medulloblastoma / Q000401:mortality / Q000532:radiotherapy*; D008875:Middle Aged; D011379:Prognosis; D011882:Radiotherapy, High-Energy